EXHIBIT 99.1
October 25, 2007
Dow Reports Third Quarter Results
Solid Increases in Price and Volume
Drive Record Quarterly Sales with Healthy Earnings
Third Quarter of 2007 Highlights
• Sales for the three months ended September 30 were $13.6 billion, 10 percent higher than the same period in 2006 and a new quarterly record for the Company, with double-digit increases in Europe, Asia Pacific and Latin America.
• Profit before tax for the third quarter of 2007 was $1.1 billion, compared with $670 million in 2006. These amounts included a $59 million pretax charge in the current quarter for purchased in-process research and development related to recent acquisitions, and pretax charges totaling $579 million for restructuring activities in the same period last year.
• Dow reported earnings of $0.42 per share, which included a significant unfavorable tax impact related to a change in German tax law and the charge for purchased in-process research and development referenced above. Earnings for the quarter also reflected a higher underlying tax rate than seen in recent quarters.
• Year over year, volume improved 5 percent, the strongest growth since the third quarter of 2004, with particularly robust demand in Europe, Asia Pacific and Latin America.
• Compared with the same quarter last year, Dow reported price increases in every geographic area and across all operating segments, outpacing an increase of almost $400 million in feedstock and energy costs.
• Equity earnings for the quarter were $296 million — down compared with the record $317 million posted in the same period last year.
Comment
Andrew N. Liveris, Dow’s chairman and chief executive officer, stated:
“This was another sound quarter for Dow. We posted record quarterly sales with substantial growth in Europe, Asia Pacific and Latin America; we achieved solid price increases across every business and in every geographic region; we saw sound volume improvements in all but one of our operating segments; and our equity earnings were once again outstanding. All of this underscores that our strategy to grow internationally — and to develop joint ventures that secure competitively advantaged feedstocks — is working … and this will continue to be our focus over the next several years.”
®TM Trademark of The Dow Chemical Company or an affiliated company of Dow.
|
| 3 Months Ended |
| 9 Months Ended |
| ||||||||
(In millions, except for per share amounts) |
| 2007 |
| 2006 |
| 2007 |
| 2006 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net Sales |
| $ | 13,589 |
| $ | 12,359 |
| $ | 39,286 |
| $ | 36,888 |
|
Net Income |
| $ | 403 |
| $ | 512 |
| $ | 2,415 |
| $ | 2,749 |
|
Earnings per Common Share |
| $ | 0.42 |
| $ | 0.53 |
| $ | 2.49 |
| $ | 2.82 |
|
Earning per Common Share |
| $ | 0.84 |
| $ | 0.98 |
| $ | 2.91 |
| $ | 3.27 |
|
Review of Third Quarter Results
The Dow Chemical Company (NYSE: DOW) reported record sales of $13.6 billion for the third quarter of 2007, a 10 percent increase compared with the same period in 2006.
Profit before tax for the third quarter was $1.1 billion, including a $59 million pretax charge for purchased in-process research and development costs related to recent acquisitions. This compares with $670 million in 2006, which included pretax charges totaling $579 million for restructuring activities.
Net income for the third quarter was $403 million, reflecting the impact of a charge to the tax provision of $362 million arising from a change in German tax law and the charge for purchased in-process research and development referenced previously.* This compares with net income for the same period last year of $512 million, including the impact of the charges for restructuring activities.
Dow reported earnings of $0.42 per share, including the impact of the items referenced above and reflecting a higher underlying tax rate than seen in recent quarters.
Year over year, volume improved 5 percent, the strongest growth since the third quarter of 2004. Demand was particularly robust in Europe, Asia Pacific and Latin America, which saw increases of 7 percent, 7 percent and 9 percent, respectively. North America also saw increased demand, despite continued weakness in the U.S. housing and automotive sectors, while India, the Middle East and Africa (“IMEA”) reported a decrease in volume, reflecting the divestiture of the Safripol business in South Africa during the fourth quarter of 2006. The Company recorded solid price gains in all operating segments, with virtually all businesses posting year-over-year increases. Price was up in all regions, with the strongest gains outside North America.
The Company’s continued focus on price/volume management across its diverse geographic and business portfolio played a key role in offsetting the relentless pace of feedstock and energy costs, which continued to climb, adding more than $380 million compared with the same period in 2006. Despite this increase, the Company was once again able to achieve some level of margin recovery.
The quarter also saw another excellent contribution from Dow’s joint ventures, with equity earnings of $296 million, down from the record $317 million posted in the same quarter a year ago. Strong contributions from Dow Corning, EQUATE and MEGlobal mitigated the impact of turnarounds at OPTIMAL, lower licensing revenue at Univation and weather-related limitations on gas availability at Compañía MEGA.
“This was another sound quarter for Dow. We posted record quarterly sales with substantial growth in Europe, Asia Pacific and Latin America; we achieved solid price increases across every business and in every geographic region; we saw strong volume improvements in all but one of our operating segments; and our equity earnings were once again outstanding,” said Andrew N. Liveris, Dow’s chairman and chief executive officer.
“All of this underscores that our strategy to grow internationally — and to develop joint ventures that secure competitively advantaged feedstocks — is working … and this will continue to be our focus over the next several years. We will continue to enhance our global footprint. We will invest in organic growth opportunities and well-targeted acquisitions that strengthen our Performance business portfolio. We will look to further expand our joint venture activities. And we will maintain a diverse, integrated business portfolio. That’s what has brought us another quarter of healthy results, and it is what we expect to deliver even greater value to our shareholders going forward.”
* — see table of certain items for further information concerning German tax law change
Performance Plastics
In the Performance Plastics segment, sales for the third quarter were $3.88 billion, an increase of 12 percent compared with the same period in 2006. Volume climbed 7 percent, with very good demand in Europe, Asia Pacific, Latin America and IMEA more than offsetting a decline in North America. Price increased 5 percent, with improvements in every geographic area and all businesses. The segment reported particularly robust sales from Polyurethanes and Polyurethane Systems, driven by continued healthy demand for both toluene diisocyanate (TDI) and methylene diphenyl diisocyanate (MDI) in a tight industry supply environment. Year-over-year sales were also bolstered by the acquisition of Hyperlast Limited polyurethane systems in the second quarter of 2007, and the formation of the Dow Izolan joint venture in 2006 — which continues to successfully expand its customer base in Russia. The Specialty Plastics and Elastomers portfolio achieved its third
consecutive quarter of record sales, with particular strength in the Performance Elastomers and Plastomers business, which reported continued high demand for ENGAGE™ polyolefin elastomers and early success with its newly launched INFUSE™ olefin block copolymers. The segment’s Wire and Cable business also reported a good quarter, as ongoing demand for fiber optic cable worldwide and for power distribution products in Europe and Asia Pacific more than offset a decline in U.S. housing and automotive applications. Third quarter EBIT(1) for the segment was $409 million, compared with $144 million in the same period last year which included restructuring charges of $242 million.
®TM Trademark of The Dow Chemical Company or an affiliated company of Dow.
(1) Earnings before interest, income taxes and minority interests (“EBIT”). A reconciliation of EBIT to “Net Income Available for Common Stockholders” is provided following the Operating Segments table.
Performance Chemicals
Sales in the Performance Chemicals segment were $2.15 billion for the third quarter of 2007, 7 percent higher than the $2.01 billion in the same period last year. Volume increased 3 percent, as double-digit growth in Europe, Latin America and IMEA was partly offset by a sharp downturn in North America and a modest decline in Asia Pacific. Price moved up 4 percent, reflecting gains in all geographic areas and particularly solid year-over-year increases in Europe and Asia Pacific. Within the Designed Polymers business, Dow Water Solutions reported another healthy increase in revenues. Sales of Omex components continued to build momentum and the business experienced good demand for ion exchange resins and FILMTEC™ liquid membranes, particularly for domestic drinking water applications. Also within Designed Polymers, the newly formed Dow Wolff Cellulosics business, which combines Dow Water Soluble Polymers with Wolff Walsrode, acquired by Dow at the end of the second quarter, reported sound industry fundamentals and good growth across all industry segments. By contrast, Dow Latex saw volumes drop from the same period last year, reflecting weak conditions within the coated paper and carpet industries, and a continued decline in architectural coating demand in North America. Equity earnings in the Performance Chemicals segment remained virtually flat with the same quarter in 2006, as an improvement in earnings from Dow Corning helped to offset a decline at OPTIMAL caused by operational issues. Performance Chemicals reported EBIT of $219 million, down from $286 million a year ago, largely the consequence of costs associated with the integration of Wolff Walsrode and some temporary outages, both planned and unplanned. Results for third quarter 2007 included a charge of $9 million for purchased in-process research and development related to the acquisition of Wolff Walsrode, while results for third quarter 2006 included restructuring charges of $11 million.
Agricultural Sciences
The Agricultural Sciences segment posted sales of $788 million, a new third quarter record and 19 percent higher than last year’s previous best of $662 million. Volume increased 16 percent compared with the same period in 2006, with good gains across most geographic areas, while price rose 3 percent, up in all geographic areas outside North America. Latin America had an outstanding quarter, reflecting significant growth in Brazil where sales were up more than 50 percent compared with the third quarter of 2006. Approximately 10 percent of the increase in Brazil sales came from Agromen, the corn seeds business acquired by Dow at the beginning of August. For the most part, however, the improvement was driven by a strong economic recovery in Brazil, where increased sugar cane acres and a good corn season spurred healthy demand for commodity herbicides. Sales of spinosad insecticide products also benefited from improved fundamentals in the Brazilian farming industry, as well as new growth initiatives in India and Asia Pacific. The third quarter also saw continued success for Dow’s healthy oils platform, with growing interest in Omega-9 canola and sunflower oils in North America, from both the restaurant trade and the food processing industry. Third quarter EBIT for Agricultural Sciences of $15 million was reduced by a $50 million charge for purchased in-process research and development related to four recent acquisitions — a significant improvement from breakeven results in 2006.
Basic Plastics
Basic Plastics sales rose 7 percent in the third quarter, from $3.11 billion in 2006 to $3.32 billion in 2007. Price was up 5 percent, with healthy improvements in all geographic areas outside North America and a double-digit increase in Europe. Volume edged 2 percent higher compared with the same period last year, as robust demand in Europe and Asia Pacific more than offset a decline in volume due to last year’s plant shutdowns in Canada and the sale of the Company’s Safripol business in South Africa. Once again, the Polyethylene business reported a solid quarter, with double-digit sales increases in both Europe and Asia Pacific compared with the same period last year. Fundamentals remained sound across the globe, with solid demand from a broad variety of end-use applications, including packaging, where polyethylene is increasingly being used as a more sustainable alternative to glass and metal. Polypropylene and Polystyrene also posted healthy results. Polypropylene recorded good demand in both North America and Europe, enabling price increases and allowing the business to shift more of its product to higher-value applications including pipe and durable goods. Polystyrene also saw healthy demand, resulting in higher prices across all geographic areas, with double-digit increases in both Europe and Latin America. Asia Pacific reported significant year-over-year volume growth, supported by demand for STYRON A-TECH™ polystyrene resins as a
replacement for acrylonitrile butadiene styrene resins. Equity earnings declined in the third quarter of 2007 compared with the same period last year, as better results at EQUATE failed to offset a decline at Equipolymers due in part to the change in German tax laws - and a decline at Siam Polyethylene. Third quarter EBIT for the Basic Plastics segment was $556 million, compared with $592 million in the same period in 2006 which included restructuring charges of $16 million.
Basic Chemicals
Third quarter sales in the Basic Chemicals segment rose 3 percent compared with a year ago, from $1.46 billion to $1.51 billion. Volume declined slightly, falling 2 percent as growth in Asia Pacific and Latin America proved insufficient to counter declines in Europe and North America, due in part to plant shutdowns in 2006. Price improved 5 percent, with increases in every geographic area. Caustic soda reported a solid third quarter, with price up significantly compared with the same period last year and volume ahead slightly. Industry fundamentals remain strong, reflecting supply shortages in most geographic areas and rising global demand from the alumina industry. By contrast, vinyl chloride monomer prices fell slightly in the third quarter compared with the same period in 2006, as continued weakness in North American residential construction contributed to softer industry conditions. In Ethylene Oxide / Ethylene Glycol, the business reported strong price increases, but volume was down — principally the consequence of an extended plant outage in North America. The industry saw good demand across all geographic areas, with particular strength in Asia Pacific where polyester demand from the clothing industry more than offset a seasonal slowdown in polyethylene terephthalate applications. Compared with the same period a year ago, equity earnings were up 15 percent, from $100 million to $115 million, as better results at EQUATE and MEGlobal offset a decline at OPTIMAL. Basic Chemicals reported EBIT for the third quarter of $205 million, compared with last year’s $122 million which included a restructuring charge of $165 million.
Outlook
Commenting on the Company’s outlook, Liveris said, “Global economic conditions remain reasonably healthy, even though there may be some concerns about the resilience of the U.S. economy going forward. There is particular strength in demand in the emerging regions of Eastern Europe, Asia Pacific and Latin America, and with Dow’s excellent international footprint, we are well-placed to capitalize on the solid growth that we are seeing in these areas, as well as in many other parts of the world.
“However, our most pressing challenge remains high and volatile feedstock and energy costs. We will mitigate these headwinds, as we have for several years, through a focus on aggressive actions to maintain margins, and through our joint ventures, which have competitive feedstock positions.
“We have the right strategy, and we intend to continue to deliver solid results for our shareholders.”
Up-coming webcast
• Dow will host a live webcast of its third quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 10:00 a.m. EDT on www.dow.com.
About Dow
Dow is a diversified chemical company that harnesses the power of innovation, science and technology to constantly improve what is essential to human progress. The Company offers a broad range of products and services to customers in more than 175 countries, helping them to provide everything from fresh water, food and pharmaceuticals to paints, packaging and personal care products. Built on a commitment to its principles of sustainability, Dow has annual sales of $49 billion and employs 43,000 people worldwide. References to “Dow” or the “Company” mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.
Note: The forward-looking statements contained in this document involve risks and uncertainties that may affect the Company’s operations, markets, products, services, prices and other factors as discussed in filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
Supplemental Information
Description of Certain Items Affecting Results:
Earnings in the third quarter of 2007 were unfavorably impacted by pretax charges totaling $59 million for purchased in-process research and development. Of this amount, $50 million was related to the recent acquisition of assets of Agromen, Exelixis, Duo Maize and Maize Technologies International and is reflected in Agricultural Sciences. The remaining $9 million charge for purchased in-process research and development was related to the acquisition of Wolff Walsrode on June 30, 2007, and is reflected in Performance Chemicals. Earnings in the quarter were further impacted by a charge of $362 million against the provision for income taxes related to a change in German tax law enacted in August 2007, which reduced the German income tax rate, resulting in a reduction in the value of the Company’s net deferred tax assets in Germany.
Earnings in the third quarter of 2006 included pretax restructuring charges totaling $579 million associated with the Company’s plan to shut down a number of assets around the world. For a breakdown of these charges by operating segment, see the Operating Segment tables at the end of this earnings release.
The following table summarizes the impact of certain items recorded in the three-month periods ended September 30, 2007 and 2006, and previously described in this section:
|
| Pretax |
| Impact on |
| Impact on |
| ||||||||||||
|
| Three Months Ended |
| Three Months Ended |
| Three Months Ended |
| ||||||||||||
In millions, except per share amounts |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| ||||||
Restructuring charges |
| - |
| $ | (579 | ) | - |
| $ | (438 | ) | - |
| $ | (0.45 | ) | |||
Purchased in-process research and |
| $ | (59 | ) | - |
| $ | (39 | ) | - |
| $ | (0.04 | ) | - |
| |||
German tax law change |
| - |
| - |
| (362 | ) | - |
| (0.38 | ) | - |
| ||||||
Total |
| $ | (59 | ) | $ | (579 | ) | $ | (401 | ) | $ | (438 | ) | $ | (0.42 | ) | $ | (0.45 | ) |
Effective tax rate: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Reported |
| 60.7 | % |
|
|
|
|
|
|
|
|
|
| ||||||
Excluding German tax law change |
| 27.4 | % |
|
|
|
|
|
|
|
|
|
|
(1) Impact on “Income before Income Taxes and Minority Interests”
(2) Impact on “Net Income Available for Common Stockholders”
(3) Impact on “Earnings per common share — diluted”
Financial Statements (Note A)
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
In millions, except per share amounts (Unaudited) |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| ||||
Net Sales |
| $ | 13,589 |
| $ | 12,359 |
| $ | 39,286 |
| $ | 36,888 |
|
Cost of sales |
| 11,864 |
| 10,600 |
| 33,867 |
| 31,027 |
| ||||
Research and development expenses |
| 329 |
| 291 |
| 951 |
| 856 |
| ||||
Selling, general and administrative expenses |
| 476 |
| 420 |
| 1,371 |
| 1,210 |
| ||||
Amortization of intangibles |
| 22 |
| 13 |
| 51 |
| 37 |
| ||||
Restructuring charges (credit) (Note B) |
| — |
| 579 |
| (4 | ) | 579 |
| ||||
Purchased in-process research and development charges (Note C) |
| 59 |
| — |
| 59 |
| — |
| ||||
Equity in earnings of nonconsolidated affiliates |
| 296 |
| 317 |
| 828 |
| 717 |
| ||||
Sundry income - net |
| 70 |
| 4 |
| 262 |
| 87 |
| ||||
Interest income |
| 28 |
| 48 |
| 101 |
| 128 |
| ||||
Interest expense and amortization of debt discount |
| 148 |
| 155 |
| 423 |
| 462 |
| ||||
Income before Income Taxes and Minority Interests |
| 1,085 |
| 670 |
| 3,759 |
| 3,649 |
| ||||
Provision for income taxes (Note D) |
| 659 |
| 137 |
| 1,271 |
| 831 |
| ||||
Minority interests’ share in income |
| 23 |
| 21 |
| 73 |
| 69 |
| ||||
Net Income Available for Common Stockholders |
| $ | 403 |
| $ | 512 |
| $ | 2,415 |
| $ | 2,749 |
|
Share Data |
|
|
|
|
|
|
|
|
| ||||
Earnings per common share - basic |
| $ | 0.42 |
| $ | 0.53 |
| $ | 2.53 |
| $ | 2.85 |
|
Earnings per common share - diluted |
| $ | 0.42 |
| $ | 0.53 |
| $ | 2.49 |
| $ | 2.82 |
|
Common stock dividends declared per share of common stock |
| $ | 0.42 |
| $ | 0.375 |
| $ | 1.215 |
| $ | 1.125 |
|
Weighted-average common shares outstanding - basic |
| 948.9 |
| 959.1 |
| 955.6 |
| 963.5 |
| ||||
Weighted-average common shares outstanding - diluted |
| 961.5 |
| 969.9 |
| 968.3 |
| 975.5 |
| ||||
Depreciation |
| $ | 499 |
| $ | 492 |
| $ | 1,439 |
| $ | 1,418 |
|
Capital Expenditures |
| $ | 519 |
| $ | 420 |
| $ | 1,311 |
| $ | 1,118 |
|
Notes to the Consolidated Financial Statements:
Note A: | The unaudited interim consolidated financial statements reflect all adjustments which, in the opinion of management, are considered necessary for a fair presentation of the results for the periods covered. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2006. Except as otherwise indicated by the context, the terms “Company” and “Dow” as used herein mean The Dow Chemical Company and its consolidated subsidiaries. |
|
|
Note B: | In August 2006, Dow’s Board of Directors approved a plan to shut down a number of assets around the world as the Company continues its drive to improve the competitiveness of its global operations. As a result, the Company recorded restructuring charges totaling $579 million in the third quarter of 2006. The charges included asset write-downs and write-offs, severance costs, contract termination fees, costs for asbestos abatement and environmental remediation, and pension curtailment costs and termination benefits associated with Dow’s defined benefit plans. |
|
|
Note C: | During the third quarter of 2007, pretax charges totaling $59 million were recorded for estimated values assigned to purchased in-process research and development. $50 million was related to recent acquisitions within the Agricultural Sciences segment; $9 million was related to the acquisition of Wolff Walsrode on June 30, 2007. |
|
|
Note D: | In August 2007, a change in German tax law, which included a reduction in the German income tax rate, was enacted. As a result, the Company adjusted the value of its net deferred tax assets in Germany and recorded a charge of $362 million against the provision for income taxes in the third quarter of 2007. |
|
|
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
In millions (Unaudited) |
| Sept. 30, |
| Dec. 31, |
| ||
Assets |
|
|
|
|
| ||
Current Assets |
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 1,945 |
| $ | 2,757 |
|
Marketable securities and interest-bearing deposits |
| 1 |
| 153 |
| ||
Accounts and notes receivable: |
|
|
|
|
| ||
Trade (net of allowance for doubtful receivables - 2007: $115; 2006: $122) |
| 6,007 |
| 4,988 |
| ||
Other |
| 3,420 |
| 3,060 |
| ||
Inventories |
| 6,772 |
| 6,058 |
| ||
Deferred income tax assets - current |
| 108 |
| 193 |
| ||
Total current assets |
| 18,253 |
| 17,209 |
| ||
Investments |
|
|
|
|
| ||
Investment in nonconsolidated affiliates |
| 3,190 |
| 2,735 |
| ||
Other investments |
| 2,417 |
| 2,143 |
| ||
Noncurrent receivables |
| 412 |
| 288 |
| ||
Total investments |
| 6,019 |
| 5,166 |
| ||
Property |
|
|
|
|
| ||
Property |
| 46,607 |
| 44,381 |
| ||
Less accumulated depreciation |
| 32,397 |
| 30,659 |
| ||
Net property |
| 14,210 |
| 13,722 |
| ||
Other Assets |
|
|
|
|
| ||
Goodwill |
| 3,519 |
| 3,242 |
| ||
Other intangible assets (net of accumulated amortization - 2007: $697; 2006: $620) |
| 752 |
| 457 |
| ||
Deferred income tax assets - noncurrent |
| 3,062 |
| 4,006 |
| ||
Asbestos-related insurance receivables - noncurrent |
| 687 |
| 725 |
| ||
Deferred charges and other assets |
| 1,167 |
| 1,054 |
| ||
Total other assets |
| 9,187 |
| 9,484 |
| ||
Total Assets |
| $ | 47,669 |
| $ | 45,581 |
|
|
|
|
|
|
| ||
Liabilities and Stockholders’ Equity |
|
|
|
|
| ||
Current Liabilities |
|
|
|
|
| ||
Notes payable |
| $ | 306 |
| $ | 219 |
|
Long-term debt due within one year |
| 1,372 |
| 1,291 |
| ||
Accounts payable: |
|
|
|
|
| ||
Trade |
| 4,233 |
| 3,825 |
| ||
Other |
| 2,006 |
| 1,849 |
| ||
Income taxes payable |
| 753 |
| 569 |
| ||
Deferred income tax liabilities - current |
| 187 |
| 251 |
| ||
Dividends payable |
| 400 |
| 382 |
| ||
Accrued and other current liabilities |
| 2,277 |
| 2,215 |
| ||
Total current liabilities |
| 11,534 |
| 10,601 |
| ||
Long-Term Debt |
| 8,019 |
| 8,036 |
| ||
Other Noncurrent Liabilities |
|
|
|
|
| ||
Deferred income tax liabilities - noncurrent |
| 903 |
| 999 |
| ||
Pension and other postretirement benefits - noncurrent |
| 3,306 |
| 3,094 |
| ||
Asbestos-related liabilities - noncurrent |
| 1,061 |
| 1,079 |
| ||
Other noncurrent obligations |
| 3,378 |
| 3,342 |
| ||
Total other noncurrent liabilities |
| 8,648 |
| 8,514 |
| ||
Minority Interest in Subsidiaries |
| 400 |
| 365 |
| ||
Preferred Securities of Subsidiaries |
| 1,000 |
| 1,000 |
| ||
Stockholders’ Equity |
|
|
|
|
| ||
Common stock |
| 2,453 |
| 2,453 |
| ||
Additional paid-in capital |
| 858 |
| 830 |
| ||
Retained earnings (includes cumulative effect of adopting FIN No. 48 of $(290)) |
| 17,941 |
| 16,987 |
| ||
Accumulated other comprehensive loss |
| (1,560 | ) | (2,235 | ) | ||
Treasury stock at cost |
| (1,624 | ) | (970 | ) | ||
Net stockholders’ equity |
| 18,068 |
| 17,065 |
| ||
Total Liabilities and Stockholders’ Equity |
| $ | 47,669 |
| $ | 45,581 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Operating Segments
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
In millions (Unaudited) |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| ||||
Sales by operating segment |
|
|
|
|
|
|
|
|
| ||||
Performance Plastics |
| $ | 3,877 |
| $ | 3,463 |
| $ | 11,148 |
| $ | 10,398 |
|
Performance Chemicals |
| 2,152 |
| 2,014 |
| 6,225 |
| 5,868 |
| ||||
Agricultural Sciences |
| 788 |
| 662 |
| 2,915 |
| 2,585 |
| ||||
Basic Plastics |
| 3,316 |
| 3,106 |
| 9,390 |
| 8,889 |
| ||||
Basic Chemicals |
| 1,507 |
| 1,461 |
| 4,233 |
| 4,245 |
| ||||
Hydrocarbons and Energy |
| 1,828 |
| 1,569 |
| 5,063 |
| 4,643 |
| ||||
Unallocated and Other |
| 121 |
| 84 |
| 312 |
| 260 |
| ||||
Total |
| $ | 13,589 |
| $ | 12,359 |
| $ | 39,286 |
| $ | 36,888 |
|
EBIT(1) by operating segment |
|
|
|
|
|
|
|
|
| ||||
Performance Plastics |
| $ | 409 |
| $ | 144 |
| $ | 1,232 |
| $ | 1,282 |
|
Performance Chemicals |
| 219 |
| 286 |
| 825 |
| 949 |
| ||||
Agricultural Sciences |
| 15 |
| — |
| 505 |
| 377 |
| ||||
Basic Plastics |
| 556 |
| 592 |
| 1,612 |
| 1,561 |
| ||||
Basic Chemicals |
| 205 |
| 122 |
| 504 |
| 495 |
| ||||
Hydrocarbons and Energy |
| — |
| — |
| (1 | ) | — |
| ||||
Unallocated and Other |
| (199 | ) | (367 | ) | (596 | ) | (681 | ) | ||||
Total |
| $ | 1,205 |
| $ | 777 |
| $ | 4,081 |
| $ | 3,983 |
|
Certain items reducing EBIT by operating segment (2) |
|
|
|
|
|
|
|
|
| ||||
Performance Plastics |
| $ | — |
| $ | (242 | ) | $ | — |
| $ | (242 | ) |
Performance Chemicals |
| (9 | ) | (11 | ) | (9 | ) | (11 | ) | ||||
Agricultural Sciences |
| (50 | ) | — |
| (50 | ) | — |
| ||||
Basic Plastics |
| — |
| (16 | ) | — |
| (16 | ) | ||||
Basic Chemicals |
| — |
| (165 | ) | — |
| (165 | ) | ||||
Unallocated and Other |
| — |
| (145 | ) | — |
| (145 | ) | ||||
Total |
| $ | (59 | ) | $ | (579 | ) | $ | (59 | ) | $ | (579 | ) |
Equity in earnings of nonconsolidated affiliates by operating segment (included in EBIT) |
|
|
|
|
|
|
|
|
| ||||
Performance Plastics |
| $ | 15 |
| $ | 34 |
| $ | 55 |
| $ | 81 |
|
Performance Chemicals |
| 90 |
| 91 |
| 299 |
| 275 |
| ||||
Agricultural Sciences |
| 1 |
| 1 |
| 1 |
| 1 |
| ||||
Basic Plastics |
| 39 |
| 65 |
| 141 |
| 127 |
| ||||
Basic Chemicals |
| 115 |
| 100 |
| 270 |
| 163 |
| ||||
Hydrocarbons and Energy |
| 35 |
| 26 |
| 62 |
| 68 |
| ||||
Unallocated and Other |
| 1 |
| — |
| — |
| 2 |
| ||||
Total |
| $ | 296 |
| $ | 317 |
| $ | 828 |
| $ | 717 |
|
(1) The Company uses EBIT (which Dow defines as earnings before interest, income taxes and minority interests) as its measure of profit/loss for segment reporting purposes. EBIT includes all operating items related to the businesses and excludes items that principally apply to the Company as a whole. A reconciliation of EBIT to “Net Income Available for Common Stockholders” is provided below:
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
|
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| ||||
EBIT |
| $ | 1,205 |
| $ | 777 |
| $ | 4,081 |
| $ | 3,983 |
|
+ Interest income |
| 28 |
| 48 |
| 101 |
| 128 |
| ||||
- Interest expense and amortization of debt discount |
| 148 |
| 155 |
| 423 |
| 462 |
| ||||
- Provision for income taxes |
| 659 |
| 137 |
| 1,271 |
| 831 |
| ||||
- Minority interests’ share in income |
| 23 |
| 21 |
| 73 |
| 69 |
| ||||
Net Income Available for Common Stockholders |
| $ | 403 |
| $ | 512 |
| $ | 2,415 |
| $ | 2,749 |
|
(2) See Supplemental Information for a description of certain items affecting results in 2007 and 2006.
The Dow Chemical Company and Subsidiaries
Sales Volume and Price by Operating Segment
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
|
| Sept. 30, 2007 |
| Sept. 30, 2007 |
| ||||||||
Percentage change from prior year |
| Volume |
| Price |
| Total |
| Volume |
| Price |
| Total |
|
Operating segments |
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Plastics |
| 7 | % | 5 | % | 12 | % | 1 | % | 6 | % | 7 | % |
Performance Chemicals |
| 3 | % | 4 | % | 7 | % | 2 | % | 4 | % | 6 | % |
Agricultural Sciences |
| 16 | % | 3 | % | 19 | % | 11 | % | 2 | % | 13 | % |
Basic Plastics |
| 2 | % | 5 | % | 7 | % | 1 | % | 5 | % | 6 | % |
Basic Chemicals |
| (2 | )% | 5 | % | 3 | % | (2 | )% | 2 | % | - |
|
Hydrocarbons and Energy |
| 11 | % | 6 | % | 17 | % | 1 | % | 8 | % | 9 | % |
Total |
| 5 | % | 5 | % | 10 | % | 2 | % | 5 | % | 7 | % |
Sales by Geographic Area
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
In millions (Unaudited) |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| Sept. 30, |
| ||||
Sales by geographic area (1) |
|
|
|
|
|
|
|
|
| ||||
North America |
| $ | 5,235 |
| $ | 5,043 |
| $ | 15,274 |
| $ | 15,649 |
|
Europe |
| 4,872 |
| 4,211 |
| 14,347 |
| 12,536 |
| ||||
Asia Pacific |
| 1,571 |
| 1,399 |
| 4,518 |
| 3,900 |
| ||||
Latin America |
| 1,524 |
| 1,308 |
| 4,146 |
| 3,686 |
| ||||
India, Middle East and Africa |
| 387 |
| 398 |
| 1,001 |
| 1,117 |
| ||||
Total |
| $ | 13,589 |
| $ | 12,359 |
| $ | 39,286 |
| $ | 36,888 |
|
(1) Beginning with the earnings release for the second quarter of 2007, the Company is providing a more detailed breakdown of its sales by geographic area. Prior to the change, the geographic breakdown included sales to customers in the United States, Europe (which included the Middle East and Africa) and Rest of World (which included the Indian subcontinent). With the new breakdown, sales to customers in the Indian subcontinent, the Middle East and Africa are reported together on a separate line, and sales to customers in Europe for prior periods have been adjusted to reflect the realignment. North America includes sales to customers in the United States and Canada.
Sales Volume and Price by Geographic Area
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
|
| Sept. 30, 2007 |
| Sept. 30, 2007 |
| ||||||||
Percentage change from prior year |
| Volume |
| Price |
| Total |
| Volume |
| Price |
| Total |
|
Geographic areas |
|
|
|
|
|
|
|
|
|
|
|
|
|
North America |
| 3 | % | 1 | % | 4 | % | (1 | )% | (1 | )% | (2 | )% |
Europe |
| 7 | % | 9 | % | 16 | % | 4 | % | 10 | % | 14 | % |
Asia Pacific |
| 7 | % | 5 | % | 12 | % | 8 | % | 8 | % | 16 | % |
Latin America |
| 9 | % | 8 | % | 17 | % | 7 | % | 5 | % | 12 | % |
India, Middle East and Africa |
| (8 | )% | 5 | % | (3 | )% | (17 | )% | 7 | % | (10 | )% |
Total |
| 5 | % | 5 | % | 10 | % | 2 | % | 5 | % | 7 | % |